STAT3 and colorectal carcinoma: In contrast, Yang et al. revealed that Enalapril, an antihypertensive drug, downregulates NF-κB/STAT3-regulated proteins to overcome 5-FU resistance in CRC cells, leading to an enhanced therapeutic efficacy of 5-FU against CRC in vivo [42].